Medical Professional Publications

Need Help Navigating the Regulatory Landscape for Novel Therapies and Early Phase Clinical Trials?

Contact Chris Shilling, director of Drug and Device Development Services, if you are interested in initiating conversations or submitting an IND/IDE application to the FDA. Drug and Device Development Services guides investigators through this complex submission, review and approval process. We provide a streamlined, uniform and consistent approach to development and implementation of clinical trials.

Contact:

Christopher J. Shilling, MS
Director, Drug and Device Development Services
WA2025 | 614-722-6960 |  www.nationwidechildrens.org/DDD

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000